Franco Signor took an important step last week to inform the White House of a practice by CMS with regard to WCMSAs and the current opioid epidemic. We have all heard the statistics and agree that action must be taken with regard to overuse and the over prescribing...
On October 6, 2014, the Administration for the Drug Enforcement Administration (DEA) rescheduled hydrocodone combination products. This was in response to the epidemic sweeping our Country because of the documented increase opioid abuse. Consequently, these drugs...
On April 16, 2013, the Food & Drug Administration announced that it will not be approving generic OxyContin, the same day the patent expired for the abuse resistant type. The FDA action appears in line with national concern over the meteoric rise in opiates use...
